Synapticure Inc.

Last week, Joe Leinbach, Eric Anderson MD PhD MBA FAAN, Christie (Byrne) Lightcap from our leadership team attended the HLTH Inc. Conference in Las Vegas, exploring new breakthroughs in healthcare technology, medical advances, and organizational efficiency. We enjoyed connecting with industry partners and peers and are excited by the valuable insights we’re bringing back to further enhance support for patients and caregivers. Christie Lightcap, Synapticure’s Head of Product, shared her main takeaways: “We had a fantastic time at the HLTH conference making new connections and discovering new ways to support our patients. The rapid innovation in AI and technology is truly exciting, and we're inspired by what’s on the horizon. We are committed to staying at the forefront of these advancements and can't wait to bring even greater value to our patients, caregivers, and partners.” #HLTHConference2024 #HealthcareInnovation #HealthcareTechnology #PatientSupport #NeurodegenerativeCare

Synapticure is proud to present the results of TWO ground-breaking studies at the Northeast ALS Consortium (NEALS) conference this week. Dr. Danielle Geraldi-Samara, MD and Abigail O’Connell shared our findings on the care and treatment of neurodegenerative diseases and their impacts including: 💭 The importance of mental health care as part of a comprehensive treatment plan. Through our Collaborative Mental Health Care Program, we found our patients had a:   ✅ 30% reduction in anxiety symptoms ✅ 28% reduction in depression symptoms 🧪 How we can increase accessibility through virtual trials and drive better research. Through our successful participation in #CLENE, the first fully-remote study for ALS patients, we’re demonstrating the power of virtual trials to:  ✅ Expand access for patients living far from clinical sites. ✅ Include more underrepresented populations in research, creating more diverse and accurate data to drive medical breakthroughs. Thank you to Northeast ALS Consortium (NEALS) for hosting this impactful event. As advocates for the advancement of care, treatment, AND research of neurodegenerative diseases, we couldn’t be more honored to take part. 💙 More soon! #ClinicalResearch #AccesstoCare #MentalHealthAwareness #Alzheimers #Dementia #ALS #Parkinsons #Huntingtons

Meet Dr. Jeremy Pruzin, one of our cognitive neurologists at Synapticure. Dr. Pruzin combines his deep expertise in Alzheimer's and dementia care with a compassionate, patient-first approach: As one caregiver shared, "I forgot he was a doctor and I felt like I was talking to a friend." His commitment to addressing lifestyle and risk factors early on helps ensure better outcomes for patients while providing essential support for their caregivers. At Synapticure, we’re proud to offer wraparound services that provide guidance for both patients and their families. From personalized care plans to proactive treatment, we ensure patients have the tools they need to navigate their journey with confidence. Get started today: 🌐 synapticure.com 📱 855-255-5917 #CognitiveCare #PatientFirst #AlzheimersCare #DementiaCare #NeurodegenerativeDiseases #Synapticure

As the US faces a rising wave of cognitive decline, Synapticure is committed to addressing the growing need for neurological care through our virtual care platform. Our expert team provides comprehensive, patient-centered services, helping families navigate neurodegenerative diseases through personalized care coordination. With initiatives like Medicare's GUIDE program now supporting families impacted by #Alzheimers and related dementias, we’re seeing meaningful shifts in how care is delivered. Synapticure is proud to lead the way in making neurological care more accessible, effective, and compassionate. #NeurologicalCare #MedicareGuide #CognitiveHealth #Telehealth #DementiaCare

In honor of World Hospice and Palliative Care Day, we want to take a moment to honor the vital role of this care in improving the quality of life for people living with long-term illnesses. At Synapticure, we believe that exceptional care includes compassionate, personalized fsupport that helps patients and caregivers manage the challenges that come with neurodegenerative diseases. Our expert team is dedicated to providing palliative care that makes a real difference, helping our patients to: ✅ Manage symptoms effectively ✅ Navigate complex medical decisions with confidence ✅ Access emotional and psychological support ✅ Coordinate care with caregivers and healthcare providers ✅ Plan for the future with peace of mind We are here to walk alongside our patients and their caregivers every step of the way, ensuring they have the comprehensive care and personalized support they need. Please join us in recognizing the importance of hospice and palliative care, and celebrating the providers dedicated to improving patients’ journeys. #WorldHospiceAndPalliativeCareDay #PalliativeCare #CompassionateCare #NeurodegenerativeDiseases #Synapticure

Congratulations to our co-founder, Brian Wallach, on being named one of HealthCentral Corporation’s 2024 Chronic Health Innovators as "The Policy Change-Maker for Neurodegenerative Diseases"! This prestigious award recognizes Brian’s tireless work through I AM ALS to revolutionize care and drive policy change for those affected by neurodegenerative diseases. As a co-founder of #Synapticure, Brian’s leadership and advocacy extend far beyond any one initiative. His efforts continue to pave the way for more accessible, expert care, cutting-edge treatments, and vital clinical trials for people living with neurodegenerative diseases across the nation. At Synapticure, we are incredibly proud to be founded by such a dedicated advocate who embodies our mission of transforming neurodegenerative care. This recognition only reinforces the importance of our work in making a real, lasting impact on patients’ and caregivers’ lives. Check out the full list of honorees and join us in celebrating Brian’s remarkable contributions to neurodegenerative care: https://lnkd.in/ekb25E92 #ChronicHealthInnovator #NeurodegenerativeDiseases #PolicyChange #HealthcareInnovation #Synapticure

On this #MentalHealthAwarenessDay, we’re highlighting the importance of mental health in neurodegenerative care. Neuropsychiatric symptoms can greatly impact quality of life for those living with neurodegnerative diseases like ALS and Parkinson’s. That's why Synapticure launched a Collaborative Mental Healthcare Program in late 2023. Over just 4 months, our patients have seen a 30% reduction in anxiety and a 28% reduction in depression symptoms. With therapies like family and group sessions, we’re helping patients and caregivers manage the emotional toll of their diagnosis. We’re proud to bring these results to light today, knowing that comprehensive care includes mental health support. Learn more: https://lnkd.in/gEqi_7hG Get started now: 🌐 synapticure.com 📱 855-255-5917 #MentalHealthMatters #NeurodegenerativeDiseases #HealthcareInnovation #ALS #Parkinsons

At 37 years old, Brian Wallach received a life-altering diagnosis: ALS, a rare neurological disease that has no cure. Yet. On your next flight, watch the incredible story of how he began a movement: https://lnkd.in/gagHfdGT Prime Video & Amazon MGM Studios Katie Couric Media

🧠 Exercise is key to managing #Parkinson’s. It doesn’t just improve motor symptoms, but it also boosts #mentalhealth, brain health, and quality of life. Discover the best exercises for Parkinson’s and how they can make a difference for you: https://lnkd.in/gu2Rymzb From aerobic workouts to balance training, learn how to safely incorporate movement into your routine, improve your symptoms, and protect your brain. Ready to get started? Discover our expert care, telehealth services, and personalized programs that support you every step of the way: 🌐 synapticure.com 📱 855-255-5917 #ParkinsonsCare #Exercise #ParkinsonsSupport #MentalHealthAwarenessMonth

Our movement disorders neurologists Dr. Liz Ferluga and Dr. Jaime Hatcher-Martin, MD, PhD, FAAN had a great time attending the #MDSCongress2024 hosted by the International Parkinson and Movement Disorder Society where they explored the future of science and care. They caught up with colleagues from around the world, like Ray Dorsey - pictured here, who is one of Synapticure's Movement Disorders Advisors - to discuss the latest hot topics in Movement Disorders. Dr. Martin had this to share: "This year’s conference had a lot of great discussion regarding the need to have more objective methods of characterizing #ParkinsonDisease and its progression, especially in prodromal PD (those who will eventually develop PD but do not have clinical symptoms yet) and in the setting of clinical trials so we can better assess treatments and their effects. There was also a lot more discussion about multiple different types of pathology in movement disorders - Parkinson’s, PSP, MSA, #Huntington’s - and how it’s likely we will need to focus on multiple targets for effective treatments to slow the progression of these disorders.” We're excited to see how these discussions will drive future advancements in care and improve outcomes for those living with movement disorders.